Position history for BAKER BROS. ADVISORS LP's holdings in PRELUDE THERAPEUTICS INC
BAKER BROS. ADVISORS LP holds 10.1M shares of PRLD (PRELUDE THERAPEUTICS INC), worth $29.4M as of 2025-Q4. PRLD represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$29.4M
Current Shares
10.1M
Total Value Change
-$9.2M
Total Shares Change
0
Other major holders of PRLD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 10.1M |
0.0% |
| $29.4M |
| 0.2% |
| $2.84 |
0 |
| 2025-Q3 | Unchanged | 10.1M | 0.0% | $14.6M | 0.1% | $1.37 | 0 |
| 2025-Q2 | Unchanged | 10.1M | 0.0% | $8.2M | 0.1% | $0.79 | 0 |
| 2025-Q1 | Unchanged | 10.1M | 0.0% | $7.8M | 0.1% | $0.80 | 0 |
| 2024-Q4 | Unchanged | 10.1M | 0.0% | $12.9M | 0.1% | $1.21 | 0 |
| 2024-Q3 | Unchanged | 10.1M | 0.0% | $21M | 0.2% | $2.12 | 0 |
| 2024-Q2 | Unchanged | 10.1M | 0.0% | $38.6M | 0.5% | $3.81 | 0 |